A nurse is assessing a client who received magnesium sulfate to treat preterm labor. Which of the following clinical findings should the nurse identify as an indication of toxicity of magnesium sulfate therapy and report to the provider?

Explanation:

A. Drowsiness: Mild drowsiness is a common side effect of magnesium sulfate therapy and is not necessarily indicative of toxicity. However, severe drowsiness or lethargy can be a sign of magnesium toxicity and should be reported to the provider.

B. Facial flushing: Facial flushing is a common side effect of magnesium sulfate administration and is generally not a sign of toxicity. It is often accompanied by warmth and redness of the skin but is not considered a serious adverse reaction.

C. Nausea: Nausea is another common side effect of magnesium sulfate therapy and is usually mild and transient. It is not typically indicative of toxicity unless it is severe and persistent.

D. Respiratory depression: Respiratory depression is a critical sign of magnesium toxicity. Excessive levels of magnesium can affect neuromuscular function, leading to respiratory muscle weakness and depression. This can result in shallow or slowed breathing, decreased oxygenation, and potential respiratory failure. Respiratory depression is a serious complication that requires immediate intervention, and the nurse should report it to the provider promptly.

Explanation:

A. Rh incompatibility

Amniocentesis is not used to identify Rh incompatibility. Rh incompatibility occurs when the mother is Rh-negative, and the baby is Rh-positive, leading to potential complications if the mother develops antibodies against the baby's Rh-positive blood cells. However, this condition is typically managed through other means such as Rh immunoglobulin (RhIg) administration.

B. Fetal gender

Amniocentesis can determine the fetal gender by analyzing the chromosomes present in the fetal cells obtained from the amniotic fluid. The presence of a Y chromosome indicates a male fetus, while its absence indicates a female fetus. Therefore, fetal gender can be identified through amniocentesis.

C. Cephalopelvic disproportion

Cephalopelvic disproportion refers to a situation where the baby's head is too large to pass through the mother's pelvis during childbirth. This condition is typically diagnosed during labor based on the progress of labor and fetal descent. Amniocentesis is not used to identify cephalopelvic disproportion.

D. Anomalies in fetal chromosomes

Amniocentesis is primarily used to identify anomalies in fetal chromosomes, such as chromosomal abnormalities like Down syndrome (Trisomy 21), Trisomy 18, and Trisomy 13. It can also detect other chromosomal abnormalities and genetic disorders caused by changes in the number or structure of chromosomes.

E. Neural tube defects

Amniocentesis can detect neural tube defects, such as spina bifida and anencephaly, by analyzing levels of alpha-fetoprotein (AFP) and other markers in the amniotic fluid. Elevated levels of AFP may indicate a neural tube defect.